Meeting
2023 ASCO Annual Meeting
Real world utilization and disparities in outcome in the use of novel anti-androgen agents for metastatic prostate cancer.
Authors
Samina Hirani
Virginia Commonwealth University Health, Richmond, VA
Samina Hirani , Ashimiyu Durojaiye , Jian He , Roy T. Sabo , Asit K. Paul
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research and Quality Improvement
Track
Quality Care/Health Services Research
Sub Track
Real-World Data/Outcomes
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 6616)
DOI
10.1200/JCO.2023.41.16_suppl.6616
Abstract #
6616
Poster Bd #
108
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Sociodemographic differences in treatment and survival for patients who receive genomic tumor testing in a rural state.
First Author: Jessica DiBiase
Poster
2022 ASCO Quality Care Symposium
Palliative care utilization in metastatic prostate cancer: An analysis of the National Cancer Database.
First Author: Xinxin Wu
Poster
2022 ASCO Genitourinary Cancers Symposium
Racial disparity in survival of African-American (AA) patients diagnosed with metastatic prostate cancer: Analysis of surveillance epidemiology and end results program.
First Author: Muhammad Zain Farooq
Poster
2021 ASCO Annual Meeting
Impact of socioeconomic disparities on diagnosis and overall survival in small cell lung cancer: A National Cancer Database analysis.
First Author: Logan Roof